ANGO Angiodynamics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ANGO

Price (delayed)

$12.37

Market cap

$511.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.75

Enterprise value

$473.3M

?
Relative Growth: Rel. Growth: 32
Relative Strength: Rel. Strength: 57
Relative Valuation: Rel. Valuation: 23
Relative Profitability: Rel. Profitability: 34

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include ...

Highlights
The quick ratio has increased by 12% YoY and by 5% QoQ
ANGO's gross profit is up by 11% year-on-year
Angiodynamics's EPS has increased by 26% YoY but it has decreased by 12% from the previous quarter
ANGO's net income is up by 24% year-on-year but it is down by 13% since the previous quarter
Angiodynamics's equity has decreased by 7% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.angiodynamics.com/
Peers: LMAT MMSI TFX ICUI

Key stats

What are the main financial stats of ANGO

ANGO stock price

How has the Angiodynamics stock price performed over time
Intraday
-0.16%
1 week
1.81%
1 month
3.78%
1 year
23.82%
YTD
-3.66%
QTD
8.8%

Financial performance

How have Angiodynamics's revenue and profit performed over time
Revenue
$313.73M
Gross profit
$170.34M
Operating income
-$30.58M
Net income
-$31.39M
Gross margin
54.3%
Net margin
-10%
The company's operating margin rose by 44% YoY but it fell by 8% QoQ
ANGO's operating income is up by 38% year-on-year but it is down by 11% since the previous quarter
The company's net margin rose by 32% YoY but it fell by 11% QoQ
ANGO's net income is up by 24% year-on-year but it is down by 13% since the previous quarter

Price vs fundamentals

How does ANGO's price correlate with its fundamentals

Growth

What is Angiodynamics's growth rate over time

Valuation

What is Angiodynamics stock price valuation
P/E
N/A
P/B
2.94
P/S
1.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.51
Angiodynamics's EPS has increased by 26% YoY but it has decreased by 12% from the previous quarter
The P/B is 74% more than the 5-year quarterly average of 1.7 and 13% more than the last 4 quarters average of 2.6
Angiodynamics's equity has decreased by 7% YoY
The revenue has increased by 11% year-on-year and by 2.1% since the previous quarter
The P/S is 9% more than the last 4 quarters average of 1.5 but 3.5% less than the 5-year quarterly average of 1.7

Efficiency

How efficient is Angiodynamics business performance
Angiodynamics's ROS has increased by 35% YoY but it has decreased by 11% from the previous quarter
ANGO's ROIC is up by 33% YoY but it is down by 12% QoQ
The ROE is up by 18% year-on-year but it is down by 15% since the previous quarter
ANGO's ROA is down by 16% since the previous quarter but it is up by 16% year-on-year

Dividends

What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANGO.

Financial health

How did Angiodynamics financials performed over time
Angiodynamics's total assets is 199% higher than its total liabilities
The quick ratio has increased by 12% YoY and by 5% QoQ
The company's total liabilities fell by 12% YoY and by 6% QoQ
The company's debt is 100% lower than its equity
Angiodynamics's equity has decreased by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.